Difference between revisions of "International Federation of Pharmaceutical Manufacturers and Associations"

From Powerbase
Jump to: navigation, search
Line 1: Line 1:
 
The IFPMA describes itself as a "non-profit, non-governmental organization representing industry associations from both developed and developing countries". [http://www.ifpma.org/index.aspx]  
 
The IFPMA describes itself as a "non-profit, non-governmental organization representing industry associations from both developed and developing countries". [http://www.ifpma.org/index.aspx]  
 
It is one of the main trade groups lobbying to establish 'public-private partnerships' between the private pharmaceutical industry and public health initiatives. [http://www.haiweb.org/campaign/PPI/seminar200011.html#ftn2]
 
It is one of the main trade groups lobbying to establish 'public-private partnerships' between the private pharmaceutical industry and public health initiatives. [http://www.haiweb.org/campaign/PPI/seminar200011.html#ftn2]
 +
 +
== History ==
 +
 +
 +
 +
== Positions ==
 +
 +
 +
 +
== Individuals ==
 +
 +
IFPMA President
 +
 +
* [[Dr. Daniel Vasella]], Chairman and Chief Executive Officer Novartis International AG
 +
 +
IFPMA Vice Presidents
 +
 +
* [[Dr. Henry A. McKinnell, Jr.]], Chairman and Chief Executive Officer Pfizer Inc.
 +
*[[Haruo Naito]], President and Chief Executive Officer Eisai Co. Ltd.
 +
 +
[http://www.ifpma.org/About_Us/about_council.aspx]
 +
 +
Directors
 +
 +
* [[Dr. Harvey E. Bale, Jr.]], Director General
 +
* [[Dr. Odette Morin]], Director, Regulatory and Scientific Affairs
 +
* [[Dr. Eric Noehrenberg]], Director, International Trade and Market Policy
 +
* [[Dr. Ryoko Krause]], Director, Biologicals and Vaccines
 +
* [[Dr. Frédérique Santerre]], Health Care Systems (ad-interim)
 +
* [[Mr. Guy Willis]], Director of Communications
 +
* [[Mr. Takeshi Sano]], Japan Liaison Executive
 +
 +
[http://www.ifpma.org/About_Us/about_sec.aspx]
 +
 +
== Members ==
 +
 +
Members are national or regional pharmaceutical industry associations in more than 60 countries and the following “research-based pharmaceutical, biotech, and vaccine companies”:
 +
 +
* [[Abbott Laboratories]]
 +
* [[Akzo Nobel – Organon]]
 +
* [[Almirall-Prodesfarma]]
 +
* [[AstraZeneca]]
 +
* [[Bayer]]
 +
* [[Boehringer Ingelheim]]
 +
* [[Bristol-Myers Squibb]]
 +
* [[Chugai Pharmaceutical]]
 +
* [[Eisai]]
 +
* [[Eli Lilly]]
 +
* [[Esteve]]
 +
* [[F-Hoffmann-La Roche]]
 +
* [[Astellas Pharma Inc.]]
 +
* [[GlaxoSmithKline]]
 +
* [[Merck & Co., Inc.]]
 +
* [[Menarini S.A.]]
 +
* [[Merck KGaA]]
 +
* [[Novartis International AG]]
 +
* [[Pfizer]]
 +
* [[Sanofi-Aventis]]
 +
* [[Institut de Recherches Internationales Servier – I.R.I.S.]]
 +
* [[Sigma-Tau]]
 +
* [[Schering AG]]
 +
* [[Schering-Plough]]
 +
* [[Takeda]]
 +
* [[Wyeth]]
 +
 +
[http://www.ifpma.org/About_Us/about_mem_americas.aspx]
 +
 +
== External links ==

Revision as of 18:40, 21 April 2006

The IFPMA describes itself as a "non-profit, non-governmental organization representing industry associations from both developed and developing countries". [1] It is one of the main trade groups lobbying to establish 'public-private partnerships' between the private pharmaceutical industry and public health initiatives. [2]

History

Positions

Individuals

IFPMA President

IFPMA Vice Presidents

[3]

Directors

[4]

Members

Members are national or regional pharmaceutical industry associations in more than 60 countries and the following “research-based pharmaceutical, biotech, and vaccine companies”:

[5]

External links

Retrieved from "https://powerbase.info/index.php?title=International_Federation_of_Pharmaceutical_Manufacturers_and_Associations&oldid=7691"